ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013